EBUS-MB Medical Services in China

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive diagnostic procedure used primarily to evaluate mediastinal and hilar lymphadenopathy, suspected lung cancer staging, sarcoidosis, tuberculosis, lymphoma, and other granulomatous or malignant conditions. Performed under conscious sedation via flexible bronchoscopy, EBUS-TBNA combines real-time ultrasound imaging with fine-needle aspiration to obtain cytological or histological samples from mediastinal lymph nodes—typically stations 2R, 4R, 7, and 10R—without surgical mediastinoscopy. Its diagnostic sensitivity exceeds 90% for malignancy and 85–90% for granulomatous disease, with specificity approaching 100%. Compared to conventional TBNA or mediastinoscopy, EBUS-TBNA offers superior visualization of vascular structures, reduced complication rates (<1% pneumothorax or bleeding), and same-day discharge in most cases.

China has emerged as a leading destination for EBUS-TBNA due to its high-volume academic centers—such as Peking Union Medical College Hospital and Shanghai Ruijin Hospital—staffed by pulmonologists certified by the Chinese Thoracic Society and trained in advanced interventional bronchoscopy. State-of-the-art Olympus and Pentax EBUS systems, coupled with rapid on-site cytopathology evaluation (ROSE), enhance diagnostic yield. Over 15,000 annual EBUS-TBNA procedures are performed nationwide, with published success rates ≥93% and complication rates below international benchmarks. Costs average USD 1,200–1,800—40–60% lower than in the US or Western Europe—without compromising quality or accreditation standards (JCI- or CNAS-certified facilities). As a dedicated medical tourism agency, we facilitate seamless access for international patients: coordinating appointments with top-tier respiratory specialists, providing itemized, transparent pricing in advance, arranging visa support, accommodation, and bilingual clinical liaison services—from pre-procedure consultation through post-procedure follow-up.

Medical Travel to China Guide: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA)

All international patients require a valid Chinese visa—typically an M (business) or Q2 (family visit) visa, which our agency helps secure within 5–7 working days via expedited embassy coordination. Medical insurance is not mandatory but highly recommended; we assist in verifying coverage for EBUS-TBNA abroad and provide transparent, all-inclusive pricing upfront—covering consultation, procedure, anesthesia, pathology, and hospital stay—with no hidden fees. Payment is accepted via bank transfer, credit card, or Alipay/WeChat Pay (with currency conversion support). We arrange comfortable, hospital-proximate accommodation—including options with kitchenettes—and can coordinate visas and travel logistics for one companion at no extra service fee. Post-procedure, our dedicated care coordinators schedule follow-up teleconsultations with your treating pulmonologist, share digital pathology reports and imaging within 48 hours, and facilitate seamless remote review with your home-country physician. We also offer 30-day post-discharge support for symptom monitoring, medication guidance, and urgent clinical queries—all included in your package. Let us handle the details while you focus on recovery.